C12ORF51 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.344800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.663600E-01
Normal-vs-Stage2
1.139250E-01
Normal-vs-Stage3
1.533590E-01
Normal-vs-Stage4
6.519600E-01
Stage1-vs-Stage2
2.490000E-01
Stage1-vs-Stage3
4.808400E-02
Stage1-vs-Stage4
6.474400E-01
Stage2-vs-Stage3
1.611180E-04
Stage2-vs-Stage4
3.136600E-01
Stage3-vs-Stage4
4.587700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.708000E-01
Normal-vs-AfricanAmerican
3.467600E-01
Normal-vs-Asian
1.768380E-01
Caucasian-vs-AfricanAmerican
8.759800E-01
Caucasian-vs-Asian
4.550200E-01
AfricanAmerican-vs-Asian
6.681600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.478600E-01
Normal-vs-Female
3.395600E-01
Male-vs-Female
9.225200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.366400E-01
Normal-vs-Age(41-60Yrs)
5.429800E-01
Normal-vs-Age(61-80Yrs)
2.798000E-01
Normal-vs-Age(81-100Yrs)
6.290300E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.567800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.230600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.737000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.165700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.508100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.492200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.083160E-01
Normal-vs-Daily Drinker
1.344960E-01
Normal-vs-Weekly Drinker
2.560400E-01
Normal-vs-Occasional Drinker
6.038400E-01
Normal-vs-Social Drinker
8.523000E-01
Non Drinker-vs-Daily Drinker
8.514200E-01
Non Drinker-vs-Weekly Drinker
6.931000E-01
Non Drinker-vs-Occasional Drinker
1.174030E-01
Non Drinker-vs-Social Drinker
1.828150E-01
Daily Drinker-vs-Weekly Drinker
8.186800E-01
Daily Drinker-vs-Occasional Drinker
1.883810E-01
Daily Drinker-vs-Social Drinker
2.173800E-01
Weekly Drinker-vs-Occasional Drinker
3.682400E-01
Weekly Drinker-vs-Social Drinker
3.018800E-01
Occasional Drinker-vs-Social Drinker
7.123200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.861050E-01
Normal-vs-Grade 2
1.729770E-02
Normal-vs-Grade 3
1.084230E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.978590E-01
Grade 1-vs-Grade 3
2.657000E-01
Grade 1-vs-Grade 4
1.861050E-01
Grade 2-vs-Grade 3
6.878000E-01
Grade 2-vs-Grade 4
1.729770E-02
Grade 3-vs-Grade 4
1.084230E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.475160E-01
Normal-vs-NonDiabetic
3.813400E-01
Diabetic-vs-NonDiabetic
3.461400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.910020E-01
Normal-vs-NoPancreatitis
3.444800E-01
Pancreatitis-vs-NoPancreatitis
8.165200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.772000E-01
Normal-vs-N1
1.277240E-01
N0-vs-N1
3.459400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.007010E-01
Normal-vs-TP53-NonMutant
8.812400E-01
TP53-Mutant-vs-TP53-NonMutant
3.120200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
